AI assistant
IMMUTEP LIMITED — Capital/Financing Update 2007
Nov 21, 2007
65122_rns_2007-11-21_bb712056-1fc1-4052-a395-d699762ceacb.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
ABN 90 009 237 889
==> picture [193 x 51] intentionally omitted <==
22[nd] November 2007
Company Announcements Office Australian Securities Exchange Level 45, Rialto South Tower 525 Collins Street Melbourne VIC 3000
Dear Sir/Madam,
Rights Issue Closed
The Directors are pleased to announce that the Company’s 1:2 Non-Renounceable Rights Issue is closed with over 15% of the entitlement taken up.
The Company has received total acceptances for listed shares issued under the Rights Issue of 15,170,970 at an issue price of $0.02 cents per share raising a total of $303,419 (before costs).
Notice of the shortfall of 83,855,668 shares has been given to the underwriter, RM Capital Pty Ltd.
Yours faithfully
==> picture [172 x 73] intentionally omitted <==
Robert Kleine Company Secretary
Prima BioMed Limited , Suite 1, 1233 High Street, Armadale, VIC 3143 AUSTRALIA Ph: +61 (0)3 9854 5700 Fax: +61 (0)3 9822 7735 www.primabiomed.com.au